26.1-36.11-03. Comprehensive medication management advisory committee

26.1-36.11-03. Comprehensive medication management advisory committee 1. The commissioner shall establish and facilitate an advisory committee to implement the provisions of this chapter. The advisory committee shall develop best practice recommendations for the implementation of comprehensive medication management and on standards to ensure pharmacists are adequately included and appropriately utilized in participating provider networks of health benefit plans. In developing these standards, the committee also shall discuss topics as they relate to implementation, including program quality measures, pharmacist training and credentialing, provider directories, care coordination, health benefit plan data reporting requirements, billing standards, and potential cost-savings and cost increases to consumers. 2. The commissioner or the commissioner's designee shall create an advisory committee, including representatives of the following stakeholders: a. The commissioner or designee; b. The state health officer or designee; c. An organization representing pharmacists; d. An organization representing physicians; e. An organization representing hospitals; f. A community pharmacy with pharmacists providing medical services; g. The two largest health carriers in the state based upon enrollment; h. The North Dakota state university school of pharmacy; i. An employer as a health benefit plan sponsor; j. An enrollee; k. An organization representing advanced practice registered nurses; and l. Other representatives appointed by the insurance commissioner. 3. No later than June 30, 2024, the advisory committee shall present initial best practice recommendations to the insurance commissioner and the department of health and human services. The commissioner or department of health and human services may adopt rules to implement the standards developed by the advisory committee. The advisory committee shall remain intact to assist the insurance commissioner or department of health and human services in rulemaking. Upon completion of the rulemaking process, the committee is dissolved.